Skip to content

KingfirthHealthandFitness

  • Personal Health
  • Medications
  • Family Health
  • Health News
  • Health Problems
  • Kids Health
  • Beauty & Balance

Home » (ravulizumab-cwvz)

28/10/2020

Alexion Receives FDA Approval for New Advanced Formulation of Ultomiris (ravulizumab-cwvz) with Significantly Reduced Infusion Time

BOSTON–(BUSINESS WIRE)–Oct. 12, 2020– Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the U.S. Food and Drug Administration (FDA) has approved Ultomiris

Continue reading »
Health Problems
How is Climate Change Impacting Our Health?
daridorexant
gefapixant
Medications
FDA Approves Kimyrsa
FDA Approves Cosela
When Your Chance for a Covid Shot Comes, Don’t Worry About the Numbers
Health News
Cleveland Clinic researchers evaluate smartphone ECG in post a-fib ablation care
A new international consortium to promote stem cell-based therapy for Huntington’s disease
What you need to know about your COVID-19 vaccine card
Copyright © 2021